Cargando…
Development of a Multiplex Autoantibody Test for Detection of Lung Cancer
Lung cancer is the leading cause of cancer-related deaths for both men and women. Early diagnosis of lung cancer has a 5-year survival rate of 48.8%, however, nearly 35% of stage I patients relapses after surgical resection, thus portending a poor prognosis. Therefore, detecting lung cancer in early...
Autores principales: | Jia, Jing, Wang, Wenzhe, Meng, Wen, Ding, Mingjian, Ma, Shenglin, Wang, Xiaoju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995760/ https://www.ncbi.nlm.nih.gov/pubmed/24755629 http://dx.doi.org/10.1371/journal.pone.0095444 |
Ejemplares similares
-
Multiplexed Serum Biomarkers for the Detection of Lung Cancer
por: Ma, Shenglin, et al.
Publicado: (2016) -
MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
por: Li, Weili, et al.
Publicado: (2016) -
Multiplex Autoantibody Detection in Patients with Autoimmune Polyglandular Syndromes
por: Savvateeva, Elena N., et al.
Publicado: (2021) -
The role of autoantibody detection in the diagnosis and staging of lung cancer
por: Wang, Yun, et al.
Publicado: (2021) -
Comparison of multiplex, ELISA and immunofluorescence for detecting autoantibodies in JIA patients
por: Fawcett, Paul T, et al.
Publicado: (2012)